StageBio Acquires TPL Path Labs to Expand its Footprints Globally

October 21, 2020 Auto Bot Acquisition, Expands, M&A, MedTech 0

Shots:

  • StageBio and TPL Path Labs offers an expanded array of histopathology, molecular pathology, and related solutions to biopharma, medical device and academic researchers across the US, EU, and other countries
  • The acquisition expands StageBio’s pre/ clinical laboratory resources, GLP/GCLP-compliant lab facility and staff in Germany tits existing 6 GLP-compliant lab facilities and 2 GLP specimen archive sites in the US
  • The acquisition enhances StageBio ability to support clinical investigators in the areas of biomarker development, TCR and immunohistochemistry

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Harman Professional Solutions

The post StageBio Acquires TPL Path Labs to Expand its Footprints Globally first appeared on PharmaShots.